454 related articles for article (PubMed ID: 22751174)
21. Mediators of cerebral hypoperfusion and blood-brain barrier leakiness in Alzheimer's disease, vascular dementia and mixed dementia.
Tayler H; Miners JS; Güzel Ö; MacLachlan R; Love S
Brain Pathol; 2021 Jul; 31(4):e12935. PubMed ID: 33410232
[TBL] [Abstract][Full Text] [Related]
22. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
23. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
[TBL] [Abstract][Full Text] [Related]
24. Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease.
Hartz AM; Miller DS; Bauer B
Mol Pharmacol; 2010 May; 77(5):715-23. PubMed ID: 20101004
[TBL] [Abstract][Full Text] [Related]
25. The pericyte: a forgotten cell type with important implications for Alzheimer's disease?
Winkler EA; Sagare AP; Zlokovic BV
Brain Pathol; 2014 Jul; 24(4):371-86. PubMed ID: 24946075
[TBL] [Abstract][Full Text] [Related]
26. Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease.
Nelson AR; Sweeney MD; Sagare AP; Zlokovic BV
Biochim Biophys Acta; 2016 May; 1862(5):887-900. PubMed ID: 26705676
[TBL] [Abstract][Full Text] [Related]
27. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.
Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W
J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814
[TBL] [Abstract][Full Text] [Related]
28. Amyloid Beta-Mediated Neurovascular Toxicity in Alzheimer's Disease.
Banerjee S; Banerjee S
Methods Mol Biol; 2024; 2761():355-372. PubMed ID: 38427250
[TBL] [Abstract][Full Text] [Related]
29. Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease.
Sengillo JD; Winkler EA; Walker CT; Sullivan JS; Johnson M; Zlokovic BV
Brain Pathol; 2013 May; 23(3):303-10. PubMed ID: 23126372
[TBL] [Abstract][Full Text] [Related]
30. The Neurovascular Unit Dysfunction in Alzheimer's Disease.
Soto-Rojas LO; Pacheco-Herrero M; Martínez-Gómez PA; Campa-Córdoba BB; Apátiga-Pérez R; Villegas-Rojas MM; Harrington CR; de la Cruz F; Garcés-Ramírez L; Luna-Muñoz J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670754
[TBL] [Abstract][Full Text] [Related]
31. Blood-brain-barrier models for the investigation of transporter- and receptor-mediated amyloid-β clearance in Alzheimer's disease.
Pflanzner T; Kuhlmann CR; Pietrzik CU
Curr Alzheimer Res; 2010 Nov; 7(7):578-90. PubMed ID: 20704558
[TBL] [Abstract][Full Text] [Related]
32. Interactions between Beta-Amyloid and Pericytes in Alzheimer's Disease.
Li YY; Guo DD; Duan RN; Li Y
Front Biosci (Landmark Ed); 2024 Apr; 29(4):136. PubMed ID: 38682184
[TBL] [Abstract][Full Text] [Related]
33. The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease.
Deane R; Sagare A; Zlokovic BV
Curr Pharm Des; 2008; 14(16):1601-5. PubMed ID: 18673201
[TBL] [Abstract][Full Text] [Related]
34. Amyloid-β peptides, Alzheimer's disease and the blood-brain barrier.
Gosselet F; Saint-Pol J; Candela P; Fenart L
Curr Alzheimer Res; 2013 Dec; 10(10):1015-33. PubMed ID: 24156262
[TBL] [Abstract][Full Text] [Related]
35. Lipopolysaccharide impairs amyloid β efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier.
Erickson MA; Hartvigson PE; Morofuji Y; Owen JB; Butterfield DA; Banks WA
J Neuroinflammation; 2012 Jun; 9():150. PubMed ID: 22747709
[TBL] [Abstract][Full Text] [Related]
36. Clearance of amyloid-β peptide across the choroid plexus in Alzheimer's disease.
Alvira-Botero X; Carro EM
Curr Aging Sci; 2010 Dec; 3(3):219-29. PubMed ID: 20735345
[TBL] [Abstract][Full Text] [Related]
37. [Blood-brain barrier and Alzheimer's disease].
Kuwahara H; Nishida Y; Yokota T
Brain Nerve; 2013 Feb; 65(2):145-51. PubMed ID: 23399672
[TBL] [Abstract][Full Text] [Related]
38. Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: relation with cerebral amyloid angiopathy and Alzheimer's disease.
Bourassa P; Tremblay C; Schneider JA; Bennett DA; Calon F
Acta Neuropathol; 2019 May; 137(5):801-823. PubMed ID: 30729296
[TBL] [Abstract][Full Text] [Related]
39. Impaired Amyloid Beta Clearance and Brain Microvascular Dysfunction are Present in the Tg-SwDI Mouse Model of Alzheimer's Disease.
Rosas-Hernandez H; Cuevas E; Raymick JB; Robinson BL; Sarkar S
Neuroscience; 2020 Aug; 440():48-55. PubMed ID: 32450297
[TBL] [Abstract][Full Text] [Related]
40. Differing associations between Aβ accumulation, hypoperfusion, blood-brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease.
Miners JS; Schulz I; Love S
J Cereb Blood Flow Metab; 2018 Jan; 38(1):103-115. PubMed ID: 28151041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
